4 Findings About Curcumin Capsules for Period Cramps

A large improvement also occurred with placebo

A 2021 trial¹ enrolled 124 women with both PMS and primary dysmenorrhea, meaning period pain without an identified underlying pelvic disorder. Participants received 500 mg curcuminoid or placebo daily, from seven days before until three days after menstruation began, for three cycles.¹

Pain fell 64% in the curcumin group and 53.3% in the placebo group. The authors described the effects as comparable. Quoting the 64% alone would overstate what the capsule demonstrated: improvement within a treatment group does not establish an advantage over its comparator.¹

One newer trial found a difference below one point

A 2025 Tabriz trial² included 62 students aged 18 to 25 with PMS and period pain. Its 500 mg capsule combined curcumin with phosphatidylcholine to enhance absorption. Dosing ran from seven days before to three days after menstruation began, for two cycles, followed by a cycle without capsules.²

At cycle two, the adjusted difference favored curcumin by 0.8 points on a 0-to-10 pain scale. A similar difference remained in cycle three. Participants could use rescue ibuprofen, but the researchers did not record exact consumption. That leaves uncertainty about how much accompanying pain medicine contributed to the scores.²

A larger reported benefit comes with unclear counts

A separate 2025 Hamadan trial³ used 500 mg curcumin capsules daily, from two days before to three days after bleeding began, for two cycles. At cycle two, mean pain scores were 3.44 with curcumin versus 6.18 with placebo, from starting values of 6.50 and 6.06.³

However, the methods describe 74 randomized participants, most tables show 34 per group, and the main pain table labels the curcumin group 32. Those conflicting denominators make the analysis harder to assess. This was also a selected group of students aged 18 to 24, rather than women with established causes such as endometriosis.³

Enhanced absorption also needs a safety discussion

The U.S. National Center for Complementary and Integrative Health⁴ warns that liver injury has been reported with some curcumin formulations designed for greater absorption. The Tabriz trial used phosphatidylcholine; other products use black-pepper piperine. These formulations should not be assumed interchangeable with plain turmeric powder.²⁴

Bring the ingredient label to a pharmacist or clinician before medicinal use. Stop the supplement and seek medical advice for dark urine, yellow skin or eyes, nausea or poor appetite. Turmeric supplements may be unsafe during pregnancy; information about larger-than-food amounts while breastfeeding is limited.⁴

Keep worsening pain on the appointment list

Arrange assessment if pain disrupts daily activities or periods become more painful. Seek urgent local medical advice if pain is severe or worse than usual and painkillers have not helped.⁵

The “The Supplement Aisle” section of Period, Handled explains how small studies, changing formulations and limited safety reporting affect supplement claims. Take the bottle label and a record of pain and painkiller use to the appointment.